Status:
COMPLETED
Hyperbaric Oxygen and Fibromyalgia: Randomised Prospective Clinical Trial
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Fibromyalgia
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on patients suffering from chronic pain syndrome (Fibromyalgia).
Detailed Description
The study is a prospective, randomized, cross-over trial. Patients will be randomized into two groups (test and control) to receive the HBOT at the beginning of the trial or 2 months afterwards. The c...
Eligibility Criteria
Inclusion
- fibromyalgia diagnosed by physical examination of pain sensitivity, by Dolorimeter and finger pressure.
Exclusion
- any past hyperbaric oxygen therapy
- chest x-ray pathology which does not allow the income into the hyperbaric chamber.
- middle ear problems.
- patients, who cannot "pump", equals middle ear pressure, effectively.
- patients who suffer from claustrophobia.
- inability or Refusing to sign the Informed Consent Form
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01827683
Start Date
May 1 2010
End Date
December 1 2012
Last Update
April 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hyperbaric unit, Assaf- Harofe Medical Center
Ẕerifin, Zerifin, Israel, 70300